Endometriosis and oxidative stress. Treatment rationale in endometriosis-associated infertility

In: Voprosy ginekologii, akušerstva i perinatologii · 2023 · vol. 22(1) , pp. 69–75 · doi:10.20953/1726-1678-2023-1-69-75 · W4360597159
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

Oxidative stress, which reflects an imbalance between the manifestations of reactive oxygen species in the body and a biological system’s ability to readily detoxify the reactive intermediates, is of considerable importance among the mechanisms of endometriosis development. Disturbances in the redox state of cells can lead to toxic effects through the production of peroxides and free radicals. The data presented in this review indicate the necessity to include antioxidant agents capable of suppressing several important manifestations of oxidative stress in the complex of treatment measures for endometriosis. The most active antioxidants include resveratrol, which has anti-inflammatory, anti-proliferative, and immunomodulatory effects. In addition to resveratrol, it is recommended to include indole-3-carbinol, a compound with a multifaceted anti-proliferative effect, in the comprehensive treatment of patients with endometriosis. Conclusion. Endometriosis is a disease of multiple etiology. One of the mechanisms of its development is oxidative stress. Therefore, it is essential to include antioxidant agents in the treatment of patients with endometriosis to relieve the negative manifestations of oxidative stress. Key words: endometriosis, oxidative stress, infertility, resveratrol, indole-3-carbinol

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK